Abstract

Incidence rate of articular cartilage injury is increasing. As cartilage is a highly differentiated tissue without direct supply of blood or nerve and has limited regeneration potential after injury, treatment of cartilage injury still poses a major challenge for both patients and orthopedic surgeons. Mesenchymal stem cells (MSCs) are a class of pluripotent stem cells with potent proliferative capacity and chondrogenic ability, and are being used to repair articular cartilage injury through tissue engineering. The aim of this article is to provide a comprehensive review of MSC transplantation for the treatment of articular cartilage injury. Key words: Cartilage; Repair; Mesenchymal stem cells; Tissue engineering

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.